These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 37553878)

  • 1. Selecting Treatment for IgA Nephropathy.
    McGuire M
    Clin J Am Soc Nephrol; 2023 Sep; 18(9):1109-1110. PubMed ID: 37553878
    [No Abstract]   [Full Text] [Related]  

  • 2. How I Treat IgA Nephropathy.
    Reich HN; Floege J
    Clin J Am Soc Nephrol; 2022 Aug; 17(8):1243-1246. PubMed ID: 35675911
    [No Abstract]   [Full Text] [Related]  

  • 3. IgA nephropathy presenting as rapidly progressive glomerulonephritis following first dose of COVID-19 vaccine.
    Niel O; Florescu C
    Pediatr Nephrol; 2022 Feb; 37(2):461-462. PubMed ID: 34786589
    [No Abstract]   [Full Text] [Related]  

  • 4. Considering the Treatment of IgA Nephropathy.
    Lafayette RA; Kamal FS
    Clin J Am Soc Nephrol; 2023 Sep; 18(9):1113-1115. PubMed ID: 37533148
    [No Abstract]   [Full Text] [Related]  

  • 5. Targeting APRIL in the Treatment of IgA Nephropathy.
    Cheung CK; Barratt J; Carroll K; Lafayette RA; Liew A; Suzuki Y; Tesař V; Trimarchi H; Wong MG; Zhang H; Perkovic V; Rizk DV
    Clin J Am Soc Nephrol; 2024 Mar; 19(3):394-398. PubMed ID: 37801688
    [No Abstract]   [Full Text] [Related]  

  • 6. IgA nephropathy: an update.
    Julian BA; Novak J
    Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):171-9. PubMed ID: 15202611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The beneficial effect of oral calcitriol treatment on proteinuria in IgA nephropathy: another point of view.
    Shin JI; Lee JS
    Am J Kidney Dis; 2008 Oct; 52(4):804-5; author reply 805. PubMed ID: 18805351
    [No Abstract]   [Full Text] [Related]  

  • 8. [Therapy in IgA nephropathy--when and how to do it].
    Vas T; Kovács T; Késoi I; Sági B; Degrell P; Wittmann I; Nagy J
    Orv Hetil; 2011 Dec; 152(51):2039-46. PubMed ID: 22130201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new role of SGLT-2 - treatment of IgA-nephropathy?
    Junaid SZS; Mehdi Khan MM; Fatma H
    J Pak Med Assoc; 2023 Jan; 73(1):213. PubMed ID: 36842051
    [No Abstract]   [Full Text] [Related]  

  • 10. Is the NefIgArd trial a paradigm shift in the treatment of IgA nephropathy?
    Gutiérrez E; Caravaca-Fontán F; Sevillano Á
    Kidney Int; 2023 May; 103(5):994. PubMed ID: 37085261
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of Hydroxychloroquine on Proteinuria in IgA Nephropathy: A Systematic Review and Meta-Analysis.
    Zhang J; Lu X; Feng J; Li H; Wang S
    Biomed Res Int; 2021; 2021():9171715. PubMed ID: 34901280
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial protease for the treatment of IgA nephropathy.
    Eitner F; Floege J
    Nephrol Dial Transplant; 2008 Jul; 23(7):2173-5. PubMed ID: 18403434
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunoglobulin A1 protease: a new therapeutic candidate for immunoglobulin A nephropathy.
    Xie LS; Huang J; Qin W; Fan JM
    Nephrology (Carlton); 2010 Aug; 15(5):584-6. PubMed ID: 20649880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Concomitant therapy with prednisolone and cyclophosphamide in 18 cases of IgA nephropathy].
    Kawaguchi S; Matsuzaki T; Sato R; Katsumata Y
    Nihon Naika Gakkai Zasshi; 1986 May; 75(5):611-7. PubMed ID: 3746074
    [No Abstract]   [Full Text] [Related]  

  • 15. Update on treatment of immunoglobulin A nephropathy.
    Zhang YM; Zhang H
    Nephrology (Carlton); 2018 Oct; 23 Suppl 4():62-67. PubMed ID: 30298661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Poly-IgA Complexes and Disease Severity in IgA Nephropathy.
    Zhang X; Lv J; Liu P; Xie X; Wang M; Liu D; Zhang H; Jin J
    Clin J Am Soc Nephrol; 2021 Nov; 16(11):1652-1664. PubMed ID: 34607844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TJN-259 improves mesangial lesions in experimental immunoglobulin A nephropathy in ddY mice.
    Sadakane C; Hattori T; Koseki J; Inagaki Y; Hasegawa Y; Shindo S; Takeda S; Takeda H
    Biol Pharm Bull; 2009 Oct; 32(10):1728-33. PubMed ID: 19801835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. APRIL - Springtime for New IgA Nephropathy Therapy?
    Lemley KV; Glassock RJ
    N Engl J Med; 2024 Jan; 390(1):80-81. PubMed ID: 38169494
    [No Abstract]   [Full Text] [Related]  

  • 19. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glomerular morphology, natural history and treatment of children with IgA-IgG mesangial nephropathy.
    McEnery PT; McAdams AJ; West CD
    Perspect Nephrol Hypertens; 1973; 1 Pt 1():305-20. PubMed ID: 4620921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.